UK contractor is held in GSK inquiry
Source: Agencies |
July 21, 2013, Sunday
|
Print Edition
Print Edition
CHINESE authorities have arrested a British contractor as part of an inquiry linked to allegations of bribery and corruption at drugmaker GlaxoSmithKline (GSK), Britain's Foreign Office and a source familiar the matter said yesterday.
Last week, Chinese police accused GSK of bribing officials and doctors to boost sales and raise the price of its medicines in China. They said GSK transferred up to 3 billion yuan (US$489 million) to 700 travel agencies and consultancies over six years to facilitate the bribes.
"We are aware of the arrest of the British national in Shanghai in China on July 10," a British Foreign Office spokesman said. "We are providing consular assistance to the family."
The spokesman did not have any further details.
However, a source familiar with the situation said the arrested man was from an international business risk advisory firm who had worked with the pharmaceuticals sector in China.
A spokesman for GSK, Britain's biggest drugmaker, said the man had never been an employee of GSK but gave no further details.
On Friday, GSK chief executive Andrew Witty sent its head of emerging markets and two other executives to China to address the crisis and help Chinese authorities get to the bottom of allegations it called "shameful" and which have shaken confidence in GSK's internal procedures.
China has already detained four senior Chinese executives and banned GSK's finance chief in China, Steve Nechelput, from leaving the country.
Britain's Times newspaper reported yesterday that the arrested Briton was part of a swoop in Beijing and Shanghai in the past week which had seen at least 10 corporate intelligence consultants detained or arrested.
The paper, which based its report on unnamed sources, said the round-up extended to other drugmakers working in China, and said Chinese investigators were building their case on information from at least two insiders, possibly embedded within GSK's Chinese operations since 2006.
Belgian drugmaker UCB said on Thursday its office in Shanghai had been visited by officials from the State Administration for Industry and Commerce seeking information on compliance.
Last week, Chinese police accused GSK of bribing officials and doctors to boost sales and raise the price of its medicines in China. They said GSK transferred up to 3 billion yuan (US$489 million) to 700 travel agencies and consultancies over six years to facilitate the bribes.
"We are aware of the arrest of the British national in Shanghai in China on July 10," a British Foreign Office spokesman said. "We are providing consular assistance to the family."
The spokesman did not have any further details.
However, a source familiar with the situation said the arrested man was from an international business risk advisory firm who had worked with the pharmaceuticals sector in China.
A spokesman for GSK, Britain's biggest drugmaker, said the man had never been an employee of GSK but gave no further details.
On Friday, GSK chief executive Andrew Witty sent its head of emerging markets and two other executives to China to address the crisis and help Chinese authorities get to the bottom of allegations it called "shameful" and which have shaken confidence in GSK's internal procedures.
China has already detained four senior Chinese executives and banned GSK's finance chief in China, Steve Nechelput, from leaving the country.
Britain's Times newspaper reported yesterday that the arrested Briton was part of a swoop in Beijing and Shanghai in the past week which had seen at least 10 corporate intelligence consultants detained or arrested.
The paper, which based its report on unnamed sources, said the round-up extended to other drugmakers working in China, and said Chinese investigators were building their case on information from at least two insiders, possibly embedded within GSK's Chinese operations since 2006.
Belgian drugmaker UCB said on Thursday its office in Shanghai had been visited by officials from the State Administration for Industry and Commerce seeking information on compliance.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
